Clinical Research Trials Archive – Closed Trials

This is our archive of closed clinical trials, which means that they are no longer accepting new participants or have been concluded. Once a research facility has chosen to close the study, it is sorted into the GPS archive by indication. If you are interested in enrolling in a clinical trial, then please browse our list of active clinical studies.

Zip code

Condition


Search Radius:25 Miles
  • 5
  • 10
  • 15
  • 20
  • 25
  • 30
  • 40
  • 50
  • 100
  • 500
  • All

We've found
161,353
archived clinical trials in
Cancer

Clinical Study of Vorinostat in Combination With Etoposide in Pediatric Patients < 21 Years at Diagnosis With Refractory Solid Tumors
A Phase I/II Clinical Study of Vorinostat in Combination With Etoposide in Pediatric Patients < 21 Years at Diagnosis With Refractory Solid Tumors
Status: Enrolling
Updated:  12/31/1969
Children's Hospital Colorado
mi
from
Aurora, CO
Clinical Study of Vorinostat in Combination With Etoposide in Pediatric Patients < 21 Years at Diagnosis With Refractory Solid Tumors
A Phase I/II Clinical Study of Vorinostat in Combination With Etoposide in Pediatric Patients < 21 Years at Diagnosis With Refractory Solid Tumors
Status: Enrolling
Updated: 12/31/1969
Children's Hospital Colorado
mi
from
Aurora, CO
Click here to add this to my saved trials
Clinical Study of Vorinostat in Combination With Etoposide in Pediatric Patients < 21 Years at Diagnosis With Refractory Solid Tumors
A Phase I/II Clinical Study of Vorinostat in Combination With Etoposide in Pediatric Patients < 21 Years at Diagnosis With Refractory Solid Tumors
Status: Enrolling
Updated:  12/31/1969
Arnold Palmer Hospital for Children/MD Anderson Cancer Center Orlando
mi
from
Orlando, FL
Clinical Study of Vorinostat in Combination With Etoposide in Pediatric Patients < 21 Years at Diagnosis With Refractory Solid Tumors
A Phase I/II Clinical Study of Vorinostat in Combination With Etoposide in Pediatric Patients < 21 Years at Diagnosis With Refractory Solid Tumors
Status: Enrolling
Updated: 12/31/1969
Arnold Palmer Hospital for Children/MD Anderson Cancer Center Orlando
mi
from
Orlando, FL
Click here to add this to my saved trials
Clinical Study of Vorinostat in Combination With Etoposide in Pediatric Patients < 21 Years at Diagnosis With Refractory Solid Tumors
A Phase I/II Clinical Study of Vorinostat in Combination With Etoposide in Pediatric Patients < 21 Years at Diagnosis With Refractory Solid Tumors
Status: Enrolling
Updated:  12/31/1969
John Hopkins Medical Center
mi
from
Baltimore, MD
Clinical Study of Vorinostat in Combination With Etoposide in Pediatric Patients < 21 Years at Diagnosis With Refractory Solid Tumors
A Phase I/II Clinical Study of Vorinostat in Combination With Etoposide in Pediatric Patients < 21 Years at Diagnosis With Refractory Solid Tumors
Status: Enrolling
Updated: 12/31/1969
John Hopkins Medical Center
mi
from
Baltimore, MD
Click here to add this to my saved trials
Clinical Study of Vorinostat in Combination With Etoposide in Pediatric Patients < 21 Years at Diagnosis With Refractory Solid Tumors
A Phase I/II Clinical Study of Vorinostat in Combination With Etoposide in Pediatric Patients < 21 Years at Diagnosis With Refractory Solid Tumors
Status: Enrolling
Updated:  12/31/1969
Dana-Farber Cancer Institute
mi
from
Boston, MA
Clinical Study of Vorinostat in Combination With Etoposide in Pediatric Patients < 21 Years at Diagnosis With Refractory Solid Tumors
A Phase I/II Clinical Study of Vorinostat in Combination With Etoposide in Pediatric Patients < 21 Years at Diagnosis With Refractory Solid Tumors
Status: Enrolling
Updated: 12/31/1969
Dana-Farber Cancer Institute
mi
from
Boston, MA
Click here to add this to my saved trials
Clinical Study of Vorinostat in Combination With Etoposide in Pediatric Patients < 21 Years at Diagnosis With Refractory Solid Tumors
A Phase I/II Clinical Study of Vorinostat in Combination With Etoposide in Pediatric Patients < 21 Years at Diagnosis With Refractory Solid Tumors
Status: Enrolling
Updated:  12/31/1969
Children's Mercy Hospital and Clinics
mi
from
Kansas City, MO
Clinical Study of Vorinostat in Combination With Etoposide in Pediatric Patients < 21 Years at Diagnosis With Refractory Solid Tumors
A Phase I/II Clinical Study of Vorinostat in Combination With Etoposide in Pediatric Patients < 21 Years at Diagnosis With Refractory Solid Tumors
Status: Enrolling
Updated: 12/31/1969
Children's Mercy Hospital and Clinics
mi
from
Kansas City, MO
Click here to add this to my saved trials
Clinical Study of Vorinostat in Combination With Etoposide in Pediatric Patients < 21 Years at Diagnosis With Refractory Solid Tumors
A Phase I/II Clinical Study of Vorinostat in Combination With Etoposide in Pediatric Patients < 21 Years at Diagnosis With Refractory Solid Tumors
Status: Enrolling
Updated:  12/31/1969
Memorial Sloan Kettering Cancer Center
mi
from
New York, NY
Clinical Study of Vorinostat in Combination With Etoposide in Pediatric Patients < 21 Years at Diagnosis With Refractory Solid Tumors
A Phase I/II Clinical Study of Vorinostat in Combination With Etoposide in Pediatric Patients < 21 Years at Diagnosis With Refractory Solid Tumors
Status: Enrolling
Updated: 12/31/1969
Memorial Sloan Kettering Cancer Center
mi
from
New York, NY
Click here to add this to my saved trials
Clinical Study of Vorinostat in Combination With Etoposide in Pediatric Patients < 21 Years at Diagnosis With Refractory Solid Tumors
A Phase I/II Clinical Study of Vorinostat in Combination With Etoposide in Pediatric Patients < 21 Years at Diagnosis With Refractory Solid Tumors
Status: Enrolling
Updated:  12/31/1969
Pennsylvania State University College of Medicine
mi
from
Hershey, PA
Clinical Study of Vorinostat in Combination With Etoposide in Pediatric Patients < 21 Years at Diagnosis With Refractory Solid Tumors
A Phase I/II Clinical Study of Vorinostat in Combination With Etoposide in Pediatric Patients < 21 Years at Diagnosis With Refractory Solid Tumors
Status: Enrolling
Updated: 12/31/1969
Pennsylvania State University College of Medicine
mi
from
Hershey, PA
Click here to add this to my saved trials
Clinical Study of Vorinostat in Combination With Etoposide in Pediatric Patients < 21 Years at Diagnosis With Refractory Solid Tumors
A Phase I/II Clinical Study of Vorinostat in Combination With Etoposide in Pediatric Patients < 21 Years at Diagnosis With Refractory Solid Tumors
Status: Enrolling
Updated:  12/31/1969
M.D. Anderson Cancer Center
mi
from
Houston, TX
Clinical Study of Vorinostat in Combination With Etoposide in Pediatric Patients < 21 Years at Diagnosis With Refractory Solid Tumors
A Phase I/II Clinical Study of Vorinostat in Combination With Etoposide in Pediatric Patients < 21 Years at Diagnosis With Refractory Solid Tumors
Status: Enrolling
Updated: 12/31/1969
M.D. Anderson Cancer Center
mi
from
Houston, TX
Click here to add this to my saved trials
Clinical Study of Vorinostat in Combination With Etoposide in Pediatric Patients < 21 Years at Diagnosis With Refractory Solid Tumors
A Phase I/II Clinical Study of Vorinostat in Combination With Etoposide in Pediatric Patients < 21 Years at Diagnosis With Refractory Solid Tumors
Status: Enrolling
Updated:  12/31/1969
Alberta Children's Hospital
mi
from
Calgary,
Clinical Study of Vorinostat in Combination With Etoposide in Pediatric Patients < 21 Years at Diagnosis With Refractory Solid Tumors
A Phase I/II Clinical Study of Vorinostat in Combination With Etoposide in Pediatric Patients < 21 Years at Diagnosis With Refractory Solid Tumors
Status: Enrolling
Updated: 12/31/1969
Alberta Children's Hospital
mi
from
Calgary,
Click here to add this to my saved trials
Clinical Study of Vorinostat in Combination With Etoposide in Pediatric Patients < 21 Years at Diagnosis With Refractory Solid Tumors
A Phase I/II Clinical Study of Vorinostat in Combination With Etoposide in Pediatric Patients < 21 Years at Diagnosis With Refractory Solid Tumors
Status: Enrolling
Updated:  12/31/1969
All Children's Hospital
mi
from
Saint Petersburg, FL
Clinical Study of Vorinostat in Combination With Etoposide in Pediatric Patients < 21 Years at Diagnosis With Refractory Solid Tumors
A Phase I/II Clinical Study of Vorinostat in Combination With Etoposide in Pediatric Patients < 21 Years at Diagnosis With Refractory Solid Tumors
Status: Enrolling
Updated: 12/31/1969
All Children's Hospital
mi
from
Saint Petersburg, FL
Click here to add this to my saved trials
Regional Chemotherapy in Locally Advanced Pancreatic Cancer: RECLAP Trial
Regional Chemotherapy in Locally Advanced Pancreatic Cancer: RECLAP Trial
Status: Enrolling
Updated:  12/31/1969
National Institutes of Health Clinical Center, 9000 Rockville Pike
mi
from
Bethesda, MD
Regional Chemotherapy in Locally Advanced Pancreatic Cancer: RECLAP Trial
Regional Chemotherapy in Locally Advanced Pancreatic Cancer: RECLAP Trial
Status: Enrolling
Updated: 12/31/1969
National Institutes of Health Clinical Center, 9000 Rockville Pike
mi
from
Bethesda, MD
Click here to add this to my saved trials
Molecular-Genetic Mechanisms Associated With Chemotherapy-Induced Nerve Damage
Characterization of the Molecular-Genetic Mechanisms Associated With Chemotherapy-Induced Peripheral Neuropathy Progression
Status: Enrolling
Updated:  12/31/1969
National Institutes of Health Clinical Center, 9000 Rockville Pike
mi
from
Bethesda, MD
Molecular-Genetic Mechanisms Associated With Chemotherapy-Induced Nerve Damage
Characterization of the Molecular-Genetic Mechanisms Associated With Chemotherapy-Induced Peripheral Neuropathy Progression
Status: Enrolling
Updated: 12/31/1969
National Institutes of Health Clinical Center, 9000 Rockville Pike
mi
from
Bethesda, MD
Click here to add this to my saved trials
Effects of High Dose Calcitriol in Breast Cancer Patients
A Pilot Study of the Effects of High-Dose Oral Calcitriol in Breast Cancer Patients Prior to Surgery
Status: Enrolling
Updated:  12/31/1969
University of Rochester
mi
from
Rochester, NY
Effects of High Dose Calcitriol in Breast Cancer Patients
A Pilot Study of the Effects of High-Dose Oral Calcitriol in Breast Cancer Patients Prior to Surgery
Status: Enrolling
Updated: 12/31/1969
University of Rochester
mi
from
Rochester, NY
Click here to add this to my saved trials
A Study of Enzalutamide Versus Bicalutamide in Castrate Men With Metastatic Prostate Cancer
A Randomized, Double-Blind, Phase II, Efficacy and Safety Study of MDV3100 Versus Bicalutamide in Castrate Men With Metastatic Prostate Cancer
Status: Enrolling
Updated:  12/31/1969
Site US1934
mi
from
Homewood, AL
A Study of Enzalutamide Versus Bicalutamide in Castrate Men With Metastatic Prostate Cancer
A Randomized, Double-Blind, Phase II, Efficacy and Safety Study of MDV3100 Versus Bicalutamide in Castrate Men With Metastatic Prostate Cancer
Status: Enrolling
Updated: 12/31/1969
Site US1934
mi
from
Homewood, AL
Click here to add this to my saved trials
A Study of Enzalutamide Versus Bicalutamide in Castrate Men With Metastatic Prostate Cancer
A Randomized, Double-Blind, Phase II, Efficacy and Safety Study of MDV3100 Versus Bicalutamide in Castrate Men With Metastatic Prostate Cancer
Status: Enrolling
Updated:  12/31/1969
Site US1527
mi
from
Anchorage, AK
A Study of Enzalutamide Versus Bicalutamide in Castrate Men With Metastatic Prostate Cancer
A Randomized, Double-Blind, Phase II, Efficacy and Safety Study of MDV3100 Versus Bicalutamide in Castrate Men With Metastatic Prostate Cancer
Status: Enrolling
Updated: 12/31/1969
Site US1527
mi
from
Anchorage, AK
Click here to add this to my saved trials
A Study of Enzalutamide Versus Bicalutamide in Castrate Men With Metastatic Prostate Cancer
A Randomized, Double-Blind, Phase II, Efficacy and Safety Study of MDV3100 Versus Bicalutamide in Castrate Men With Metastatic Prostate Cancer
Status: Enrolling
Updated:  12/31/1969
Site US3026
mi
from
Tucson, AZ
A Study of Enzalutamide Versus Bicalutamide in Castrate Men With Metastatic Prostate Cancer
A Randomized, Double-Blind, Phase II, Efficacy and Safety Study of MDV3100 Versus Bicalutamide in Castrate Men With Metastatic Prostate Cancer
Status: Enrolling
Updated: 12/31/1969
Site US3026
mi
from
Tucson, AZ
Click here to add this to my saved trials
A Study of Enzalutamide Versus Bicalutamide in Castrate Men With Metastatic Prostate Cancer
A Randomized, Double-Blind, Phase II, Efficacy and Safety Study of MDV3100 Versus Bicalutamide in Castrate Men With Metastatic Prostate Cancer
Status: Enrolling
Updated:  12/31/1969
Site US2977
mi
from
Highland, CA
A Study of Enzalutamide Versus Bicalutamide in Castrate Men With Metastatic Prostate Cancer
A Randomized, Double-Blind, Phase II, Efficacy and Safety Study of MDV3100 Versus Bicalutamide in Castrate Men With Metastatic Prostate Cancer
Status: Enrolling
Updated: 12/31/1969
Site US2977
mi
from
Highland, CA
Click here to add this to my saved trials
A Study of Enzalutamide Versus Bicalutamide in Castrate Men With Metastatic Prostate Cancer
A Randomized, Double-Blind, Phase II, Efficacy and Safety Study of MDV3100 Versus Bicalutamide in Castrate Men With Metastatic Prostate Cancer
Status: Enrolling
Updated:  12/31/1969
Site US3630
mi
from
San Diego, CA
A Study of Enzalutamide Versus Bicalutamide in Castrate Men With Metastatic Prostate Cancer
A Randomized, Double-Blind, Phase II, Efficacy and Safety Study of MDV3100 Versus Bicalutamide in Castrate Men With Metastatic Prostate Cancer
Status: Enrolling
Updated: 12/31/1969
Site US3630
mi
from
San Diego, CA
Click here to add this to my saved trials
A Study of Enzalutamide Versus Bicalutamide in Castrate Men With Metastatic Prostate Cancer
A Randomized, Double-Blind, Phase II, Efficacy and Safety Study of MDV3100 Versus Bicalutamide in Castrate Men With Metastatic Prostate Cancer
Status: Enrolling
Updated:  12/31/1969
Site US2935
mi
from
Denver, CO
A Study of Enzalutamide Versus Bicalutamide in Castrate Men With Metastatic Prostate Cancer
A Randomized, Double-Blind, Phase II, Efficacy and Safety Study of MDV3100 Versus Bicalutamide in Castrate Men With Metastatic Prostate Cancer
Status: Enrolling
Updated: 12/31/1969
Site US2935
mi
from
Denver, CO
Click here to add this to my saved trials
A Study of Enzalutamide Versus Bicalutamide in Castrate Men With Metastatic Prostate Cancer
A Randomized, Double-Blind, Phase II, Efficacy and Safety Study of MDV3100 Versus Bicalutamide in Castrate Men With Metastatic Prostate Cancer
Status: Enrolling
Updated:  12/31/1969
Site US2945
mi
from
Middlebury, CT
A Study of Enzalutamide Versus Bicalutamide in Castrate Men With Metastatic Prostate Cancer
A Randomized, Double-Blind, Phase II, Efficacy and Safety Study of MDV3100 Versus Bicalutamide in Castrate Men With Metastatic Prostate Cancer
Status: Enrolling
Updated: 12/31/1969
Site US2945
mi
from
Middlebury, CT
Click here to add this to my saved trials
A Study of Enzalutamide Versus Bicalutamide in Castrate Men With Metastatic Prostate Cancer
A Randomized, Double-Blind, Phase II, Efficacy and Safety Study of MDV3100 Versus Bicalutamide in Castrate Men With Metastatic Prostate Cancer
Status: Enrolling
Updated:  12/31/1969
Site US2014
mi
from
Melrose Park, IL
A Study of Enzalutamide Versus Bicalutamide in Castrate Men With Metastatic Prostate Cancer
A Randomized, Double-Blind, Phase II, Efficacy and Safety Study of MDV3100 Versus Bicalutamide in Castrate Men With Metastatic Prostate Cancer
Status: Enrolling
Updated: 12/31/1969
Site US2014
mi
from
Melrose Park, IL
Click here to add this to my saved trials
A Study of Enzalutamide Versus Bicalutamide in Castrate Men With Metastatic Prostate Cancer
A Randomized, Double-Blind, Phase II, Efficacy and Safety Study of MDV3100 Versus Bicalutamide in Castrate Men With Metastatic Prostate Cancer
Status: Enrolling
Updated:  12/31/1969
Site US2067
mi
from
Springfield, IL
A Study of Enzalutamide Versus Bicalutamide in Castrate Men With Metastatic Prostate Cancer
A Randomized, Double-Blind, Phase II, Efficacy and Safety Study of MDV3100 Versus Bicalutamide in Castrate Men With Metastatic Prostate Cancer
Status: Enrolling
Updated: 12/31/1969
Site US2067
mi
from
Springfield, IL
Click here to add this to my saved trials
A Study of Enzalutamide Versus Bicalutamide in Castrate Men With Metastatic Prostate Cancer
A Randomized, Double-Blind, Phase II, Efficacy and Safety Study of MDV3100 Versus Bicalutamide in Castrate Men With Metastatic Prostate Cancer
Status: Enrolling
Updated:  12/31/1969
Site US2027
mi
from
Jeffersonville, IN
A Study of Enzalutamide Versus Bicalutamide in Castrate Men With Metastatic Prostate Cancer
A Randomized, Double-Blind, Phase II, Efficacy and Safety Study of MDV3100 Versus Bicalutamide in Castrate Men With Metastatic Prostate Cancer
Status: Enrolling
Updated: 12/31/1969
Site US2027
mi
from
Jeffersonville, IN
Click here to add this to my saved trials
A Study of Enzalutamide Versus Bicalutamide in Castrate Men With Metastatic Prostate Cancer
A Randomized, Double-Blind, Phase II, Efficacy and Safety Study of MDV3100 Versus Bicalutamide in Castrate Men With Metastatic Prostate Cancer
Status: Enrolling
Updated:  12/31/1969
Site US1838
mi
from
West Des Moines, IA
A Study of Enzalutamide Versus Bicalutamide in Castrate Men With Metastatic Prostate Cancer
A Randomized, Double-Blind, Phase II, Efficacy and Safety Study of MDV3100 Versus Bicalutamide in Castrate Men With Metastatic Prostate Cancer
Status: Enrolling
Updated: 12/31/1969
Site US1838
mi
from
West Des Moines, IA
Click here to add this to my saved trials
A Study of Enzalutamide Versus Bicalutamide in Castrate Men With Metastatic Prostate Cancer
A Randomized, Double-Blind, Phase II, Efficacy and Safety Study of MDV3100 Versus Bicalutamide in Castrate Men With Metastatic Prostate Cancer
Status: Enrolling
Updated:  12/31/1969
Site US62
mi
from
Kansas City, KA
A Study of Enzalutamide Versus Bicalutamide in Castrate Men With Metastatic Prostate Cancer
A Randomized, Double-Blind, Phase II, Efficacy and Safety Study of MDV3100 Versus Bicalutamide in Castrate Men With Metastatic Prostate Cancer
Status: Enrolling
Updated: 12/31/1969
Site US62
mi
from
Kansas City, KA
Click here to add this to my saved trials
A Study of Enzalutamide Versus Bicalutamide in Castrate Men With Metastatic Prostate Cancer
A Randomized, Double-Blind, Phase II, Efficacy and Safety Study of MDV3100 Versus Bicalutamide in Castrate Men With Metastatic Prostate Cancer
Status: Enrolling
Updated:  12/31/1969
Site US2976
mi
from
Baltimore, MD
A Study of Enzalutamide Versus Bicalutamide in Castrate Men With Metastatic Prostate Cancer
A Randomized, Double-Blind, Phase II, Efficacy and Safety Study of MDV3100 Versus Bicalutamide in Castrate Men With Metastatic Prostate Cancer
Status: Enrolling
Updated: 12/31/1969
Site US2976
mi
from
Baltimore, MD
Click here to add this to my saved trials
A Study of Enzalutamide Versus Bicalutamide in Castrate Men With Metastatic Prostate Cancer
A Randomized, Double-Blind, Phase II, Efficacy and Safety Study of MDV3100 Versus Bicalutamide in Castrate Men With Metastatic Prostate Cancer
Status: Enrolling
Updated:  12/31/1969
Site US3182
mi
from
Bethesda, MD
A Study of Enzalutamide Versus Bicalutamide in Castrate Men With Metastatic Prostate Cancer
A Randomized, Double-Blind, Phase II, Efficacy and Safety Study of MDV3100 Versus Bicalutamide in Castrate Men With Metastatic Prostate Cancer
Status: Enrolling
Updated: 12/31/1969
Site US3182
mi
from
Bethesda, MD
Click here to add this to my saved trials
A Study of Enzalutamide Versus Bicalutamide in Castrate Men With Metastatic Prostate Cancer
A Randomized, Double-Blind, Phase II, Efficacy and Safety Study of MDV3100 Versus Bicalutamide in Castrate Men With Metastatic Prostate Cancer
Status: Enrolling
Updated:  12/31/1969
Site US2975
mi
from
Ann Arbor, MI
A Study of Enzalutamide Versus Bicalutamide in Castrate Men With Metastatic Prostate Cancer
A Randomized, Double-Blind, Phase II, Efficacy and Safety Study of MDV3100 Versus Bicalutamide in Castrate Men With Metastatic Prostate Cancer
Status: Enrolling
Updated: 12/31/1969
Site US2975
mi
from
Ann Arbor, MI
Click here to add this to my saved trials
A Study of Enzalutamide Versus Bicalutamide in Castrate Men With Metastatic Prostate Cancer
A Randomized, Double-Blind, Phase II, Efficacy and Safety Study of MDV3100 Versus Bicalutamide in Castrate Men With Metastatic Prostate Cancer
Status: Enrolling
Updated:  12/31/1969
Site US892
mi
from
Grand Rapids, MI
A Study of Enzalutamide Versus Bicalutamide in Castrate Men With Metastatic Prostate Cancer
A Randomized, Double-Blind, Phase II, Efficacy and Safety Study of MDV3100 Versus Bicalutamide in Castrate Men With Metastatic Prostate Cancer
Status: Enrolling
Updated: 12/31/1969
Site US892
mi
from
Grand Rapids, MI
Click here to add this to my saved trials
A Study of Enzalutamide Versus Bicalutamide in Castrate Men With Metastatic Prostate Cancer
A Randomized, Double-Blind, Phase II, Efficacy and Safety Study of MDV3100 Versus Bicalutamide in Castrate Men With Metastatic Prostate Cancer
Status: Enrolling
Updated:  12/31/1969
Site US20
mi
from
Minneapolis, MN
A Study of Enzalutamide Versus Bicalutamide in Castrate Men With Metastatic Prostate Cancer
A Randomized, Double-Blind, Phase II, Efficacy and Safety Study of MDV3100 Versus Bicalutamide in Castrate Men With Metastatic Prostate Cancer
Status: Enrolling
Updated: 12/31/1969
Site US20
mi
from
Minneapolis, MN
Click here to add this to my saved trials
A Study of Enzalutamide Versus Bicalutamide in Castrate Men With Metastatic Prostate Cancer
A Randomized, Double-Blind, Phase II, Efficacy and Safety Study of MDV3100 Versus Bicalutamide in Castrate Men With Metastatic Prostate Cancer
Status: Enrolling
Updated:  12/31/1969
Site US3078
mi
from
Billings, MT
A Study of Enzalutamide Versus Bicalutamide in Castrate Men With Metastatic Prostate Cancer
A Randomized, Double-Blind, Phase II, Efficacy and Safety Study of MDV3100 Versus Bicalutamide in Castrate Men With Metastatic Prostate Cancer
Status: Enrolling
Updated: 12/31/1969
Site US3078
mi
from
Billings, MT
Click here to add this to my saved trials
A Study of Enzalutamide Versus Bicalutamide in Castrate Men With Metastatic Prostate Cancer
A Randomized, Double-Blind, Phase II, Efficacy and Safety Study of MDV3100 Versus Bicalutamide in Castrate Men With Metastatic Prostate Cancer
Status: Enrolling
Updated:  12/31/1969
Site US2968
mi
from
Lawrenceville, NJ
A Study of Enzalutamide Versus Bicalutamide in Castrate Men With Metastatic Prostate Cancer
A Randomized, Double-Blind, Phase II, Efficacy and Safety Study of MDV3100 Versus Bicalutamide in Castrate Men With Metastatic Prostate Cancer
Status: Enrolling
Updated: 12/31/1969
Site US2968
mi
from
Lawrenceville, NJ
Click here to add this to my saved trials
A Study of Enzalutamide Versus Bicalutamide in Castrate Men With Metastatic Prostate Cancer
A Randomized, Double-Blind, Phase II, Efficacy and Safety Study of MDV3100 Versus Bicalutamide in Castrate Men With Metastatic Prostate Cancer
Status: Enrolling
Updated:  12/31/1969
Site US3025
mi
from
Poughkeepsie, NY
A Study of Enzalutamide Versus Bicalutamide in Castrate Men With Metastatic Prostate Cancer
A Randomized, Double-Blind, Phase II, Efficacy and Safety Study of MDV3100 Versus Bicalutamide in Castrate Men With Metastatic Prostate Cancer
Status: Enrolling
Updated: 12/31/1969
Site US3025
mi
from
Poughkeepsie, NY
Click here to add this to my saved trials
A Study of Enzalutamide Versus Bicalutamide in Castrate Men With Metastatic Prostate Cancer
A Randomized, Double-Blind, Phase II, Efficacy and Safety Study of MDV3100 Versus Bicalutamide in Castrate Men With Metastatic Prostate Cancer
Status: Enrolling
Updated:  12/31/1969
Site US1675
mi
from
Rochester, NY
A Study of Enzalutamide Versus Bicalutamide in Castrate Men With Metastatic Prostate Cancer
A Randomized, Double-Blind, Phase II, Efficacy and Safety Study of MDV3100 Versus Bicalutamide in Castrate Men With Metastatic Prostate Cancer
Status: Enrolling
Updated: 12/31/1969
Site US1675
mi
from
Rochester, NY
Click here to add this to my saved trials
A Study of Enzalutamide Versus Bicalutamide in Castrate Men With Metastatic Prostate Cancer
A Randomized, Double-Blind, Phase II, Efficacy and Safety Study of MDV3100 Versus Bicalutamide in Castrate Men With Metastatic Prostate Cancer
Status: Enrolling
Updated:  12/31/1969
Site US2934
mi
from
Staten Island, NY
A Study of Enzalutamide Versus Bicalutamide in Castrate Men With Metastatic Prostate Cancer
A Randomized, Double-Blind, Phase II, Efficacy and Safety Study of MDV3100 Versus Bicalutamide in Castrate Men With Metastatic Prostate Cancer
Status: Enrolling
Updated: 12/31/1969
Site US2934
mi
from
Staten Island, NY
Click here to add this to my saved trials
A Study of Enzalutamide Versus Bicalutamide in Castrate Men With Metastatic Prostate Cancer
A Randomized, Double-Blind, Phase II, Efficacy and Safety Study of MDV3100 Versus Bicalutamide in Castrate Men With Metastatic Prostate Cancer
Status: Enrolling
Updated:  12/31/1969
Site US81
mi
from
Chapel Hill, NC
A Study of Enzalutamide Versus Bicalutamide in Castrate Men With Metastatic Prostate Cancer
A Randomized, Double-Blind, Phase II, Efficacy and Safety Study of MDV3100 Versus Bicalutamide in Castrate Men With Metastatic Prostate Cancer
Status: Enrolling
Updated: 12/31/1969
Site US81
mi
from
Chapel Hill, NC
Click here to add this to my saved trials
A Study of Enzalutamide Versus Bicalutamide in Castrate Men With Metastatic Prostate Cancer
A Randomized, Double-Blind, Phase II, Efficacy and Safety Study of MDV3100 Versus Bicalutamide in Castrate Men With Metastatic Prostate Cancer
Status: Enrolling
Updated:  12/31/1969
Site US2104
mi
from
Greensboro, NC
A Study of Enzalutamide Versus Bicalutamide in Castrate Men With Metastatic Prostate Cancer
A Randomized, Double-Blind, Phase II, Efficacy and Safety Study of MDV3100 Versus Bicalutamide in Castrate Men With Metastatic Prostate Cancer
Status: Enrolling
Updated: 12/31/1969
Site US2104
mi
from
Greensboro, NC
Click here to add this to my saved trials
A Study of Enzalutamide Versus Bicalutamide in Castrate Men With Metastatic Prostate Cancer
A Randomized, Double-Blind, Phase II, Efficacy and Safety Study of MDV3100 Versus Bicalutamide in Castrate Men With Metastatic Prostate Cancer
Status: Enrolling
Updated:  12/31/1969
Site US44
mi
from
Cincinnati, OH
A Study of Enzalutamide Versus Bicalutamide in Castrate Men With Metastatic Prostate Cancer
A Randomized, Double-Blind, Phase II, Efficacy and Safety Study of MDV3100 Versus Bicalutamide in Castrate Men With Metastatic Prostate Cancer
Status: Enrolling
Updated: 12/31/1969
Site US44
mi
from
Cincinnati, OH
Click here to add this to my saved trials
A Study of Enzalutamide Versus Bicalutamide in Castrate Men With Metastatic Prostate Cancer
A Randomized, Double-Blind, Phase II, Efficacy and Safety Study of MDV3100 Versus Bicalutamide in Castrate Men With Metastatic Prostate Cancer
Status: Enrolling
Updated:  12/31/1969
Site US2185
mi
from
Columbus, OH
A Study of Enzalutamide Versus Bicalutamide in Castrate Men With Metastatic Prostate Cancer
A Randomized, Double-Blind, Phase II, Efficacy and Safety Study of MDV3100 Versus Bicalutamide in Castrate Men With Metastatic Prostate Cancer
Status: Enrolling
Updated: 12/31/1969
Site US2185
mi
from
Columbus, OH
Click here to add this to my saved trials
A Study of Enzalutamide Versus Bicalutamide in Castrate Men With Metastatic Prostate Cancer
A Randomized, Double-Blind, Phase II, Efficacy and Safety Study of MDV3100 Versus Bicalutamide in Castrate Men With Metastatic Prostate Cancer
Status: Enrolling
Updated:  12/31/1969
Site US1598
mi
from
Bala-Cynwyd, PA
A Study of Enzalutamide Versus Bicalutamide in Castrate Men With Metastatic Prostate Cancer
A Randomized, Double-Blind, Phase II, Efficacy and Safety Study of MDV3100 Versus Bicalutamide in Castrate Men With Metastatic Prostate Cancer
Status: Enrolling
Updated: 12/31/1969
Site US1598
mi
from
Bala-Cynwyd, PA
Click here to add this to my saved trials
A Study of Enzalutamide Versus Bicalutamide in Castrate Men With Metastatic Prostate Cancer
A Randomized, Double-Blind, Phase II, Efficacy and Safety Study of MDV3100 Versus Bicalutamide in Castrate Men With Metastatic Prostate Cancer
Status: Enrolling
Updated:  12/31/1969
Site US1680
mi
from
Lancaster, PA
A Study of Enzalutamide Versus Bicalutamide in Castrate Men With Metastatic Prostate Cancer
A Randomized, Double-Blind, Phase II, Efficacy and Safety Study of MDV3100 Versus Bicalutamide in Castrate Men With Metastatic Prostate Cancer
Status: Enrolling
Updated: 12/31/1969
Site US1680
mi
from
Lancaster, PA
Click here to add this to my saved trials
A Study of Enzalutamide Versus Bicalutamide in Castrate Men With Metastatic Prostate Cancer
A Randomized, Double-Blind, Phase II, Efficacy and Safety Study of MDV3100 Versus Bicalutamide in Castrate Men With Metastatic Prostate Cancer
Status: Enrolling
Updated:  12/31/1969
Site US2926
mi
from
Myrtle Beach, SC
A Study of Enzalutamide Versus Bicalutamide in Castrate Men With Metastatic Prostate Cancer
A Randomized, Double-Blind, Phase II, Efficacy and Safety Study of MDV3100 Versus Bicalutamide in Castrate Men With Metastatic Prostate Cancer
Status: Enrolling
Updated: 12/31/1969
Site US2926
mi
from
Myrtle Beach, SC
Click here to add this to my saved trials
A Study of Enzalutamide Versus Bicalutamide in Castrate Men With Metastatic Prostate Cancer
A Randomized, Double-Blind, Phase II, Efficacy and Safety Study of MDV3100 Versus Bicalutamide in Castrate Men With Metastatic Prostate Cancer
Status: Enrolling
Updated:  12/31/1969
Site US1657
mi
from
Nashville, TN
A Study of Enzalutamide Versus Bicalutamide in Castrate Men With Metastatic Prostate Cancer
A Randomized, Double-Blind, Phase II, Efficacy and Safety Study of MDV3100 Versus Bicalutamide in Castrate Men With Metastatic Prostate Cancer
Status: Enrolling
Updated: 12/31/1969
Site US1657
mi
from
Nashville, TN
Click here to add this to my saved trials
A Study of Enzalutamide Versus Bicalutamide in Castrate Men With Metastatic Prostate Cancer
A Randomized, Double-Blind, Phase II, Efficacy and Safety Study of MDV3100 Versus Bicalutamide in Castrate Men With Metastatic Prostate Cancer
Status: Enrolling
Updated:  12/31/1969
Site US464
mi
from
Houston, TX
A Study of Enzalutamide Versus Bicalutamide in Castrate Men With Metastatic Prostate Cancer
A Randomized, Double-Blind, Phase II, Efficacy and Safety Study of MDV3100 Versus Bicalutamide in Castrate Men With Metastatic Prostate Cancer
Status: Enrolling
Updated: 12/31/1969
Site US464
mi
from
Houston, TX
Click here to add this to my saved trials
A Study of Enzalutamide Versus Bicalutamide in Castrate Men With Metastatic Prostate Cancer
A Randomized, Double-Blind, Phase II, Efficacy and Safety Study of MDV3100 Versus Bicalutamide in Castrate Men With Metastatic Prostate Cancer
Status: Enrolling
Updated:  12/31/1969
Site US2978
mi
from
San Antonio, TX
A Study of Enzalutamide Versus Bicalutamide in Castrate Men With Metastatic Prostate Cancer
A Randomized, Double-Blind, Phase II, Efficacy and Safety Study of MDV3100 Versus Bicalutamide in Castrate Men With Metastatic Prostate Cancer
Status: Enrolling
Updated: 12/31/1969
Site US2978
mi
from
San Antonio, TX
Click here to add this to my saved trials
A Study of Enzalutamide Versus Bicalutamide in Castrate Men With Metastatic Prostate Cancer
A Randomized, Double-Blind, Phase II, Efficacy and Safety Study of MDV3100 Versus Bicalutamide in Castrate Men With Metastatic Prostate Cancer
Status: Enrolling
Updated:  12/31/1969
Site US1653
mi
from
Virginia Beach, VA
A Study of Enzalutamide Versus Bicalutamide in Castrate Men With Metastatic Prostate Cancer
A Randomized, Double-Blind, Phase II, Efficacy and Safety Study of MDV3100 Versus Bicalutamide in Castrate Men With Metastatic Prostate Cancer
Status: Enrolling
Updated: 12/31/1969
Site US1653
mi
from
Virginia Beach, VA
Click here to add this to my saved trials
A Study of Enzalutamide Versus Bicalutamide in Castrate Men With Metastatic Prostate Cancer
A Randomized, Double-Blind, Phase II, Efficacy and Safety Study of MDV3100 Versus Bicalutamide in Castrate Men With Metastatic Prostate Cancer
Status: Enrolling
Updated:  12/31/1969
Site US1580
mi
from
Burien, WA
A Study of Enzalutamide Versus Bicalutamide in Castrate Men With Metastatic Prostate Cancer
A Randomized, Double-Blind, Phase II, Efficacy and Safety Study of MDV3100 Versus Bicalutamide in Castrate Men With Metastatic Prostate Cancer
Status: Enrolling
Updated: 12/31/1969
Site US1580
mi
from
Burien, WA
Click here to add this to my saved trials
A Study of Enzalutamide Versus Bicalutamide in Castrate Men With Metastatic Prostate Cancer
A Randomized, Double-Blind, Phase II, Efficacy and Safety Study of MDV3100 Versus Bicalutamide in Castrate Men With Metastatic Prostate Cancer
Status: Enrolling
Updated:  12/31/1969
Site US1709
mi
from
Wenatchee, WA
A Study of Enzalutamide Versus Bicalutamide in Castrate Men With Metastatic Prostate Cancer
A Randomized, Double-Blind, Phase II, Efficacy and Safety Study of MDV3100 Versus Bicalutamide in Castrate Men With Metastatic Prostate Cancer
Status: Enrolling
Updated: 12/31/1969
Site US1709
mi
from
Wenatchee, WA
Click here to add this to my saved trials
A Study of Enzalutamide Versus Bicalutamide in Castrate Men With Metastatic Prostate Cancer
A Randomized, Double-Blind, Phase II, Efficacy and Safety Study of MDV3100 Versus Bicalutamide in Castrate Men With Metastatic Prostate Cancer
Status: Enrolling
Updated:  12/31/1969
Site US51
mi
from
Milwaukee, WI
A Study of Enzalutamide Versus Bicalutamide in Castrate Men With Metastatic Prostate Cancer
A Randomized, Double-Blind, Phase II, Efficacy and Safety Study of MDV3100 Versus Bicalutamide in Castrate Men With Metastatic Prostate Cancer
Status: Enrolling
Updated: 12/31/1969
Site US51
mi
from
Milwaukee, WI
Click here to add this to my saved trials
A Study of Enzalutamide Versus Bicalutamide in Castrate Men With Metastatic Prostate Cancer
A Randomized, Double-Blind, Phase II, Efficacy and Safety Study of MDV3100 Versus Bicalutamide in Castrate Men With Metastatic Prostate Cancer
Status: Enrolling
Updated:  12/31/1969
Site BE3015
mi
from
Brussels,
A Study of Enzalutamide Versus Bicalutamide in Castrate Men With Metastatic Prostate Cancer
A Randomized, Double-Blind, Phase II, Efficacy and Safety Study of MDV3100 Versus Bicalutamide in Castrate Men With Metastatic Prostate Cancer
Status: Enrolling
Updated: 12/31/1969
Site BE3015
mi
from
Brussels,
Click here to add this to my saved trials